UCSC Human Gene Sorter
 
genome assembly search
sort by display output 
#
Name
VisiGene
BLASTP
E-Value
Genome Position
Description
1IL7Rn/a
n/a
n/a
n/a
0chr5 35,868,247interleukin 7 receptor, transcript variant 1 (from RefSeq NM_002185.5)
2CD2n/a
    
    
     
n/achr1 116,761,829CD2 molecule, transcript variant 2 (from RefSeq NM_001767.5)
3GZMAn/a
    
    
     
n/achr5 55,106,449granzyme A (from RefSeq NM_006144.4)
4CD7n/a
n/a
n/a
n/a
n/achr17 82,316,240CD7 molecule (from RefSeq NM_006137.7)
5TMEM150Bn/a
n/a
n/a
n/a
n/achr19 55,319,071transmembrane protein 150B, transcript variant 1 (from RefSeq NM_001282011.2)
6KLRB1n/a
    
    
     
n/achr12 9,601,233killer cell lectin like receptor B1 (from RefSeq NM_002258.3)
7CD33n/a
n/a
n/a
n/a
n/achr19 51,232,548CD33 molecule, transcript variant 1 (from RefSeq NM_001772.4)
8SIGLEC10-AS2n/a
    
    
     
n/achr19 51,414,631SIGLEC10-AS2 (from geneSymbol)
9GZMKn/a
    
    
     
n/achr5 55,029,413granzyme K (from RefSeq NM_002104.3)
10ENSG00000274845n/a
n/a
n/a
n/a
n/achr2 191,682,542ENSG00000274845 (from geneSymbol)
11SIGLEC7n/a
n/a
n/a
n/a
n/achr19 51,147,913sialic acid binding Ig like lectin 7, transcript variant 1 (from RefSeq NM_014385.4)
12ACEn/a
n/a
n/a
n/a
n/achr17 63,487,717angiotensin I converting enzyme, transcript variant 5 (from RefSeq NM_001382701.1)
13ENSG00000256072n/a
    
    
     
n/achr12 66,254,589ENSG00000256072 (from geneSymbol)
14IKZF1n/a
n/a
n/a
n/a
n/achr7 50,354,908IKAROS family zinc finger 1, transcript variant 1 (from RefSeq NM_006060.6)
15CD6n/a
n/a
n/a
n/a
n/achr11 60,996,028CD6 molecule, transcript variant 1 (from RefSeq NM_006725.5)
16ENSG00000262370n/a
n/a
n/a
n/a
n/achr16 3,082,005ENSG00000262370 (from geneSymbol)
17BANK1n/a
n/a
n/a
n/a
n/achr4 101,932,771B cell scaffold protein with ankyrin repeats 1, transcript variant 1 (from RefSeq NM_017935.5)
18TRDCn/a
n/a
n/a
n/a
n/achr14 22,464,359T cell receptor delta constant (from HGNC TRDC)
19CXCL8n/a
n/a
n/a
n/a
n/achr4 73,742,142C-X-C motif chemokine ligand 8, transcript variant 1 (from RefSeq NM_000584.4)
20SIGLEC10-AS1n/a
    
    
     
n/achr19 51,416,665SIGLEC10 antisense RNA 1, transcript variant 2 (from RefSeq NR_164125.1)
21GPR65n/a
n/a
n/a
n/a
n/achr14 88,009,973G protein-coupled receptor 65 (from RefSeq NM_003608.4)
22PLB1n/a
n/a
n/a
n/a
n/achr2 28,570,101phospholipase B1, transcript variant 1 (from RefSeq NM_153021.5)
23ENSG00000270972n/a
    
    
     
n/achr11 333,440ENSG00000270972 (from geneSymbol)
24C5AR2n/a
n/a
n/a
n/a
n/achr19 47,339,752complement C5a receptor 2, transcript variant 3 (from RefSeq NM_001271750.2)
25TRAF3IP3n/a
n/a
n/a
n/a
n/achr1 209,769,181TRAF3 interacting protein 3, transcript variant 1 (from RefSeq NM_025228.4)
26ENSG00000284697n/a
n/a
n/a
n/a
n/achr12 8,117,377ENSG00000284697 (from geneSymbol)
27DPEP2n/a
n/a
n/a
n/a
n/achr16 67,993,439dipeptidase 2, transcript variant 1 (from RefSeq NM_022355.4)
28ARHGAP25n/a
n/a
n/a
n/a
n/achr2 68,780,822Rho GTPase activating protein 25, transcript variant 5 (from RefSeq NM_001364819.1)
29PTGER2n/a
    
    
     
n/achr14 52,321,455prostaglandin E receptor 2 (from RefSeq NM_000956.4)
30CD300Cn/a
    
    
     
n/achr17 74,543,594CD300c molecule (from RefSeq NM_006678.5)
31OTULINLn/a
    
    
     
n/achr5 14,598,986OTU deubiquitinase with linear linkage specificity like (from RefSeq NM_019018.3)
32CLEC12An/a
n/a
n/a
n/a
n/achr12 9,978,502C-type lectin domain family 12 member A, transcript variant 1 (from RefSeq NM_138337.6)
33TNFRSF4n/a
n/a
n/a
n/a
n/achr1 1,212,746TNF receptor superfamily member 4, transcript variant 1 (from RefSeq NM_003327.4)
34CCL18n/a
n/a
n/a
n/a
n/achr17 36,068,152C-C motif chemokine ligand 18 (from RefSeq NM_002988.4)
35TLCD2n/a
n/a
n/a
n/a
n/achr17 1,706,596TLC domain containing 2 (from RefSeq NM_001164407.2)
36GAB3n/a
n/a
n/a
n/a
n/achrX 154,713,163GRB2 associated binding protein 3, transcript variant 1 (from RefSeq NM_001081573.3)
37TRIM25n/a
n/a
n/a
n/a
n/achr17 56,900,979tripartite motif containing 25 (from RefSeq NM_005082.5)
38MIR3614n/a
n/a
n/a
n/a
n/achr17 56,891,312microRNA 3614 (from RefSeq NR_037408.1)
39SIRPB2n/a
n/a
n/a
n/a
n/achr20 1,482,999signal regulatory protein beta 2, transcript variant 1 (from RefSeq NM_001122962.2)
40CCR1n/a
    
    
     
n/achr3 46,205,012C-C motif chemokine receptor 1 (from RefSeq NM_001295.3)
41BTNL8n/a
n/a
n/a
n/a
n/achr5 180,925,032butyrophilin like 8, transcript variant 2 (from RefSeq NM_001040462.3)
42CCRL2n/a
    
    
     
n/achr3 46,408,391C-C motif chemokine receptor like 2, transcript variant 1 (from RefSeq NM_003965.5)
43ENSG00000255446n/a
    
    
     
n/achr11 62,424,284ENSG00000255446 (from geneSymbol)
44FPR3n/a
    
    
     
n/achr19 51,810,673formyl peptide receptor 3 (from RefSeq NM_002030.5)
45ENSG00000280537n/a
n/a
n/a
n/a
n/achr2 219,122,980ENSG00000280537 (from geneSymbol)
46MGAMn/a
n/a
n/a
n/a
n/achr7 142,051,313maltase-glucoamylase, transcript variant 1 (from RefSeq NM_001365693.1)
47CARD8-AS1n/a
    
    
     
n/achr19 48,256,937CARD8 antisense RNA 1 (from RefSeq NR_040599.1)
48IGHV3-33n/a
    
    
     
n/achr14 106,360,058V region of the variable domain of immunoglobulin heavy  chains that participates in the antigen recognition (PubMed:24600447).  Immunoglobulins, also known as antibodies, are membrane-bound or  secreted glycoproteins produced by B lymphocytes. In the recognition  phase of humoral immunity, the membrane-bound immunoglobulins serve as  receptors which, upon binding of a specific antigen, trigger the clonal  expansion and differentiation of B lymphocytes into immunoglobulins-  secreting plasma cells. Secreted immunoglobulins mediate the effector  phase of humoral immunity, which results in the elimination of bound  antigens (PubMed:22158414, PubMed:20176268). The antigen binding site  is formed by the variable domain of one heavy chain, together with that  of its associated light chain. Thus, each immunoglobulin has two  antigen binding sites with remarkable affinity for a particular  antigen. The variable domains are assembled by a process called V-(D)-J  rearrangement and can then be subjected to somatic hypermutations  which, after exposure to antigen and selection, allow affinity  maturation for a particular antigen (PubMed:20176268, PubMed:17576170). (from UniProt P01772)
49CD5n/a
n/a
n/a
n/a
n/achr11 61,115,170CD5 molecule, transcript variant 1 (from RefSeq NM_014207.4)
50RASAL3n/a
n/a
n/a
n/a
n/achr19 15,458,084RAS protein activator like 3, transcript variant 10 (from RefSeq NR_174478.1)